9db394440f
Some checks failed
CI / skinny-install (ccw) (push) Successful in 30s
CI / skinny-install (cli) (push) Successful in 33s
CI / skinny-install (aco) (push) Successful in 43s
CI / lint-test (push) Failing after 1m28s
CI / skinny-install (api) (push) Successful in 33s
CI / skinny-install (bcda) (push) Successful in 29s
CI / skinny-install (bib) (push) Successful in 30s
CI / skinny-install (bls) (push) Successful in 26s
CI / skinny-install (cms) (push) Successful in 28s
CI / skinny-install (conf) (push) Successful in 26s
CI / skinny-install (perf) (push) Successful in 26s
CI / skinny-install (pfs) (push) Successful in 30s
CI / skinny-install (rex) (push) Successful in 23s
Infra CI / notebooks (push) Successful in 6s
Infra CI / zotero (push) Successful in 7s
Infra CI / docs (push) Successful in 45s
Infra CI / api (push) Successful in 15s
Infra CI / mc (push) Successful in 9s
Deploy / build-scan-report (push) Successful in 4m29s
Composite susceptibility score per product (0-1) based on: - Price (30%): ASP magnitude (kickback headroom), flat-rate delta - Evidence (25%): RCT count, industry funding, price-per-RCT ratio - Distribution (25%): office/SNF setting mix, high-risk provider usage - Price volatility (10%): anomalous QoQ spikes - FDA pathway (10%): HCT/P > 510(k) > PMA risk weighting Results: 286 products scored - 30 critical (avg ASP $3,211, avg score 0.626) - 63 high (avg ASP $1,204, avg score 0.537) - 186 moderate, 7 low Key finding: all 30 critical products are amniotic membrane with zero RCTs and ASP >$2,000/cm². XWRAP Dual: $5,560/cm², 0 RCTs, highest susceptibility — same product class as DOJ fraud targets. 19 tables in skin_subs schema.